Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy : An advisory statement from the American Dental Association Council on Scientific Affairs

Journal of the American Dental Association

Volumn 139, Issue 12, 2008, Pages 1674-1677

  Edwards, Beatrice J ^a   Hellstein, John W ^b   Jacobsen, Peter L ^c   Kaltman, Steven ^d   Mariotti, Angelo ^e   Migliorati, Cesar A ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Bisphosphonate associated osteonecrosis; Osteoporosis; osteonecrosis

Indexed keywords

EID: 58149231034     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2008.0110     Document Type: Article

References (19)

1. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. JADA 2006;137(8):1144-1150.
2. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations-report of the Council on Scientific Affairs."www.ada.org/ prof/resources/topics/topics-osteonecrosis- bisphosphonate-report.pdf" Accessed Oct. 22, 2008.
3. Grbic JT, Landesberg R, Lin SQ, et al. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial. JADA 2008;139(l):32-40.
4. Bilezikian JP. Osteonecrosis of the jaw: do bisphosphonates pose a risk? N Engl J Med 2006;355(22):2278-2281.
5. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 2008;44(9):857-869.
6. Felsenberg D, Hoffmeister B, Amling M. Bisphosphonattherapie assoziierte. Kiefernekrosen Deutsches Arzteblatt 2006;46: A3078-A3080.
7. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007;65(3):415-423.
8. Black DM, Delmas PD, Eastell R, et al.; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356(18):1809-1822.
9. Etminan M, Aminzadeh K, Matthew IR, Brophy JM. Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study. J Rheumatol 2008;35(4):691-695.
10. Cartsos VM, Zhu S, Zavras Al. Bisphosphonate use and the risk of adverse jaw outcomes. JADA2008;139(l):23-30.
11. Drug Topics. Top 200 brand-name drugs by units in 2006. "www.drugtopics.com/drugtopics/Pharmacy+Facts+And+Figures/ Top-200-brand-name-drugs-by-units-in-2006/ArticleStandard/Article/detail/407649? contextCategoryId=7604". Accessed Sept. 12, 2007.
12. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62(5):527-534.
13. U.S. Department of Health & Human Services. Bone health and osteoporosis: a report of the surgeon general (2004). "www.surgeongeneral. gov/library/bonehealtWcontent.html "http://surgeongeneral.gov/library/ bonehealtWcontent.html". Accessed Oct. 2, 2008.
14. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359(9319):1761-1767.
15. Jeffcoat MK. Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006;21(3):349-353.
16. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. J Periodontal 2007;78(3):584-594.
17. Schwartz JE. Ask us: some drugs affect tooth movement. Am J Orthod Dentofacial Orthop 2005;127(6):644.
18. Rinchuse DJ, Rinchuse DJ, Sosovicka MF, Robison JM, Pendleton R. Orthodontic treatment of patients using bisphosphonates: a report of 2 cases. Am J Orthod Dentofacial Orthop 2007;131(3):321-326.
19. Marx RE, Cillo JE, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65(12): 2397-2410.